DUBLIN, Ireland--(BUSINESS WIRE)--Mar. 19, 2014-- Covidien plc (NYSE:COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.32 per ordinary share. The dividend is payable on May 5, 2014, to shareholders of record on April 7, 2014.

About Covidien

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien develops, manufactures and sells a diverse range of industry-leading medical device and supply products. With 2013 revenue of $10.2 billion, Covidien has more than 38,000 employees worldwide in more than 70 countries, and its products are sold in over 150 countries. Please visit www.covidien.com to learn more about our business.

Source: Covidien

External Communications
Peter Lucht, 508-452-4168
Vice President
Peter.lucht@covidien.com
or
Investor Relations
Coleman Lannum, CFA, 508-452-4343
Vice President
cole.lannum@covidien.com
or
Corporate Communications
Lisa Clemence, 508-452-4375
Director
lisa.clemence@covidien.com
or
Investor Relations
Todd Carpenter, 508-452-4363
Senior Director
todd.carpenter@covidien.com